½ÃÀ庸°í¼­
»óǰÄÚµå
1524283

¹ÙÀÌ¿À ¼ÒÀç »óó µå·¹½Ì ½ÃÀå : Àç·á À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2024-2032³â)

Biomaterial Wound Dressing Market - Material Type (Natural [Alginate, Collagen], Synthetic [Polyurethane, Silicon]), Application (Chronic [Pressure, Diabetes Ulcer], Acute [Surgical & traumatic wounds, Burns]), End-user - Global Forecast (2024 - 2032)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 260 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌ¿À ¼ÒÀç »óó µå·¹½Ì ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.4%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ´Â »ýüÀç·á ¹× »óó µå·¹½Ì Àç·á ±â¼úÀÇ ±â¼úÀû Áøº¸¿Í °³ÀÎÈ­µÇ°í Çõ½ÅÀûÀÎ ¸ÂÃãÇü »óó Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔÀº °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ±â´É¼ºÀ» Çâ»ó½Ã۰í, »ý¹°ÇÐÀû ÀûÇÕ¼ºÀ» °³¼±Çϸç, ´Ù¾çÇÑ È¯ÀÚÀÇ ¿ä±¸¿¡ ¸Â´Â ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

ÀÇ·áÀÇ Áß½ÉÀÌ È¯ÀÚ Áß½ÉÀÇ Ä¡·á ¸ðµ¨°ú °¡Ä¡ ±â¹Ý ¼º°ú·Î À̵¿ÇÔ¿¡ µû¶ó ȸº¹ °úÁ¤À» °¡¼ÓÈ­Çϰí ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ´Â °í±Þ µå·¹½Ì Àç·á°¡ ÁÖ¸ñ¹Þ°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 3¿ù, IASST AssamÀÇ °úÇÐÀÚµéÀº ¹Ù³ª³ª ¼¶À¯¿Í ŰÅä»ê, ±¸¾Æ°ËÀ» È¥ÇÕÇÑ Àú·ÅÇϰí ȯ°æ ģȭÀûÀÎ ºØ´ë Àç·á¸¦ »ý»êÇß½À´Ï´Ù.

¹ÙÀÌ¿À ¼ÒÀç »óó µå·¹½Ì »ê¾÷Àº Àç·á À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

Àç·á À¯Çüº°·Î º¸¸é, 2032³â±îÁö ÇÕ¼º ºÐ¾ß´Â ´ÙÀç´Ù´ÉÇÔ°ú °í±Þ Ư¼ºÀ¸·Î ÀÎÇØ À¯¸®ÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °íºÐÀÚ °úÇÐ ¹× ¿£Áö´Ï¾î¸µÀÇ ¹ßÀüÀ¸·Î ÇÕ¼º µå·¹½Ì Àç·á´Â »ýü Á¶Á÷°úÀÇ ³ôÀº ȣȯ¼º, ¸¶¸ð ¹× ¼Õ»ó¿¡ ´ëÇÑ °­µµ, À¯¿¬¼º µî ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¹°ÁúÀº Á¶Á÷ÀÇ ÀÚ¿¬Àû Ư¼ºÀ» ¸ð¹æÇÒ ¼ö ÀÖ¾î »óó Ä¡À¯¿¡ ´õ ³ªÀº °á°ú¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)¿ë »ýüÀç·á µå·¹½Ì Àç·á ½ÃÀåÀº ¿Ü·¡ ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í È¿À²¼ºÀÌ ³ô¾ÆÁü¿¡ µû¶ó 2032³â±îÁö »ó´çÇÑ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿Ü·¡ ¼ö¼úÀº È¿°úÀûÀÎ »óó °ü¸®, Ä¡À¯ ½Ã°£ ´ÜÃà, ¼ö¼ú ÈÄ ÇÕº´Áõ °¨¼Ò¿Í °°Àº ƯÁ¤ ¿ä±¸ »çÇ×À» ÃæÁ·ÇÏ´Â »ýüÀç·á µå·¹½Ì Àç·á¿¡ ÀûÇÕÇÕ´Ï´Ù. Àúħ½ÀÀû Ä¡·á¹ý¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹ÙÀÌ¿À ¼ÒÀç »óó µå·¹½Ì »ê¾÷Àº 2024³â¿¡¼­ 2032³â°£¿¡ »ó´çÇÑ CAGRÀ» ´Þ¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× ¹è°æ¿¡´Â ±Þ¼ÓÇÑ Àα¸ Áõ°¡, ¸¸¼º »óóÀÇ È®»ê, ÀÇ·áºñ ÁöÃâ Áõ°¡°¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¢±¹ Á¤ºÎ°¡ Çö´ëÀû ÀÇ·á ÀÎÇÁ¶ó¸¦ °­È­ÇÏ°í »õ·Î¿î ÀÇ·á ±â¼úÀ» µµÀÔÇÏ·Á´Â ³ë·Â, °í·ÉÈ­ ¹× ÀÇ·á °ü±¤ÀÇ ºÎ»óµµ ÀÌ Áö¿ª ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©£¦°úÁ¦
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • ±ÔÁ¦ »óȲ
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ - °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Àç·á À¯Çüº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • õ¿¬
    • ¾Ë±ä»ê
    • Äݶó°Õ
    • ŰÅä»ê
    • Ä«º¹½Ã¸ÞÆ¿¼¿·ê·Î¿À½º(CMC)
    • ±âŸ õ¿¬ Àç·á
  • ÇÕ¼º
    • Æú¸®¿ì·¹Åº
    • ½Ç¸®ÄÜ
    • Æú¸®ºñ´Ò ¾ËÄÚ¿Ã
    • ±âŸ ÇÕ¼º Àç·á

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¸¸¼º â»ó
    • ¿åâ
    • ´ç´¢º´¼º Á·±Ë¾ç
    • Á¤¸Æ¼º Á¾¾Æ¸® ±Ë¾ç
    • ±âŸ ¸¸¼º â»ó
  • ±Þ¼º â»ó
    • ¿Ü°úÀû/¿Ü»ó¼º â»ó
    • È­»ó

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ÀçÅà ¿ä¾ç ȯ°æ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • 3M
  • B. Braun Melsungen AG
  • ConvaTec Group plc
  • DermaRite Industries LLC
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Molnlycke Health Care AB
  • Smith & Nephew plc
LSH 24.08.16

Global bio material Wound Dressing Market size will record 6.4% CAGR from 2024 to 2032, propelled by technological advancements in bio materials and wound dressing technologies coupled with the growing demand for personalized and innovative wound care solutions. These advancements are offering enhanced functionalities, improved bio compatibility, and tailored solutions for catering to diverse patient needs.

As the focus of the healthcare shifts towards patient-centered care models plus value-based outcomes, more advanced dressings capable of speeding up recovery processes and minimize complications will come to light, further driving the market expansion. For example, in March 2024, scientists at IASST Assam produced a cheap environmentally friendly bandage material made by blending banana fibers with chitosan and guar gum.

The bio material wound dressing industry is fragmented into material type, application, end-user, and region.

Based on material type, the synthetic segment will experience lucrative growth by 2032 due to its versatility and advanced properties. With the developments in polymer science and engineering, synthetic dressings provide tailored solutions like high compatibility with living tissue, strength against wear or damages and flexibility. Moreover, these substances can imitate natural characteristics of tissues while giving better outcomes in healing wounds.

By End-User, the bio material wound dressing market from the ambulatory surgical centers segment will witness substantial CAGR through 2032, owing to their growing preference and efficiency in outpatient procedures. Ambulatory surgery suits bio material dressings as they meet its specific requirements including effective wound management, faster healing time, and fewer post-operative complications. The rising interest in less invasive treatment options will also favor the segment growth.

Asia Pacific bio material wound dressing industry will achieve a remarkable CAGR between 2024 and 2032. This can be attributed to rapid population growth, the prevalence of chronic wounds alongside the increase in healthcare spending. Additionally, initiatives by governments are aiming to enhance modern healthcare infrastructure and the uptake of new medical technologies The aging people and the rise of medical tourism will also fuel the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of chronic wound
      • 3.2.1.2 Rising geriatric population
      • 3.2.1.3 Increasing number of accidents
      • 3.2.1.4 Technological advancements in wound dressings
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limited reimbursement policies
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Material Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Natural
    • 5.2.1 Alginate
    • 5.2.2 Collagen
    • 5.2.3 Chitosan
    • 5.2.4 Carboxymethyl cellulose (CMC)
    • 5.2.5 Other natural materials
  • 5.3 Synthetic
    • 5.3.1 Polyurethane
    • 5.3.2 Silicon
    • 5.3.3 Polyvinyl alcohol
    • 5.3.4 Other synthetic materials

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Chronic wounds
    • 6.2.1 Pressure ulcers
    • 6.2.2 Diabetic foot ulcers
    • 6.2.3 Venous leg ulcers
    • 6.2.4 Other chronic wounds
  • 6.3 Acute wounds
    • 6.3.1 Surgical & traumatic wounds
    • 6.3.2 Burns

Chapter 7 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Home care settings
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 3M
  • 9.2 B. Braun Melsungen AG
  • 9.3 ConvaTec Group plc
  • 9.4 DermaRite Industries LLC
  • 9.5 Hollister Incorporated
  • 9.6 Integra LifeSciences Holdings Corporation
  • 9.7 Johnson & Johnson
  • 9.8 Medtronic plc
  • 9.9 Molnlycke Health Care AB
  • 9.10 Smith & Nephew plc
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦